Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Armata Pharmaceuticals, Inc. (ARMP : AMEX)
 
 • Company Description   
Armata Pharmaceuticals Inc. is a biotechnology company. It is focused on the development of bacteriophage therapeutics for antibiotic-resistant infections using its proprietary bacteriophage-based technology. The company's principal product candidate consist AP-SA01, targets Staphylococcus aureus including multidrug-resistant strains. It is also developing and advancing a pipeline of synthetic phage candidates, including a synthetic phage for Pseudomonas aeruginosa. Armata Pharmaceuticals Inc., formerly known as AmpliPhi Biosciences Corporation, is based in Marina del Rey, California.

Number of Employees: 71

 
 • Price / Volume Information   
Yesterday's Closing Price: $4.25 Daily Weekly Monthly
20 Day Moving Average: 7,080 shares
Shares Outstanding: 36.11 (millions)
Market Capitalization: $153.48 (millions)
Beta: 1.06
52 Week High: $6.49
52 Week Low: $2.82
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -3.41% 8.78%
12 Week -18.74% -10.67%
Year To Date -22.44% -3.01%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
4503 GLENCOE AVENUE
-
MARINA DEL REY,CA 90292
USA
ph: 310-665-2928
fax: 310-665-2963
jallaire@lifesciadvisors.com http://www.armatapharma.com
 
 • General Corporate Information   
Officers
Brian Varnum - Chief Executive Officer and Director
Jules Haimovitz - Chairman
Steve R. Martin - Chief Financial Officer
Odysseas D. Kostas - Director
Robin Kramer - Director

Peer Information
Armata Pharmaceuticals, Inc. (CORR.)
Armata Pharmaceuticals, Inc. (RSPI)
Armata Pharmaceuticals, Inc. (CGXP)
Armata Pharmaceuticals, Inc. (BGEN)
Armata Pharmaceuticals, Inc. (GTBP)
Armata Pharmaceuticals, Inc. (RGRX)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED-BIOMED/GENE
Sector: Medical
CUSIP: 04216R102
SIC: 2836
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/22
Next Expected EPS Date: 08/11/22
Share - Related Items
Shares Outstanding: 36.11
Most Recent Split Date: 5.00 (0.07:1)
Beta: 1.06
Market Capitalization: $153.48 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $-0.26 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $-0.92 Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: 3.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/11/22  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 2.49
Price/Cash Flow: -
Price / Sales: 33.05
EPS Growth
vs. Year Ago Period: -11.11%
vs. Previous Quarter: -30.43%
Sales Growth
vs. Year Ago Period: 15.95%
vs. Previous Quarter: 24.97%
ROE
03/31/22 - -75.90
12/31/21 - -82.86
09/30/21 - -90.20
ROA
03/31/22 - -39.38
12/31/21 - -43.37
09/30/21 - -51.78
Current Ratio
03/31/22 - 7.82
12/31/21 - 3.11
09/30/21 - 2.70
Quick Ratio
03/31/22 - 7.82
12/31/21 - 3.11
09/30/21 - 2.70
Operating Margin
03/31/22 - -569.21
12/31/21 - -517.55
09/30/21 - -594.94
Net Margin
03/31/22 - -569.21
12/31/21 - -517.55
09/30/21 - -594.94
Pre-Tax Margin
03/31/22 - -569.21
12/31/21 - -517.55
09/30/21 - -594.94
Book Value
03/31/22 - 1.70
12/31/21 - 0.94
09/30/21 - 0.95
Inventory Turnover
03/31/22 - -
12/31/21 - -
09/30/21 - -
Debt-to-Equity
03/31/22 - 0.00
12/31/21 - 0.00
09/30/21 - 0.00
Debt-to-Capital
03/31/22 - 0.00
12/31/21 - 0.00
09/30/21 - 0.00
 

Powered by Zacks Investment Research ©